Action of tumor-inhibitory gum tragacanth on potassium permeability of ascites tumor cells and partial characterization of the cytotoxic component.
D000636:Aminosalicylic Acids; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology*; D001202:Ascitic Fluid; D002247:Carbon Isotopes; D002460:Cell Line; D002462:Cell Membrane / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects; D002478:Cells, Cultured; D002498:Centrifugation; D002848:Chromatography, DEAE-Cellulose; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009374:Neoplasms, Experimental / Q000378:metabolism* / Q000473:pathology; D011188:Potassium / Q000378:metabolism*; D011194:Potassium Isotopes; D012964:Sodium / Q000378:metabolism; D013056:Spectrophotometry, Ultraviolet; D014633:Valine / Q000378:metabolism; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000636:Aminosalicylic Acids; D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D009363:Neoplasm Proteins; D011194:Potassium Isotopes; D012964:Sodium; D014633:Valine; D011188:Potassium